Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Outcome/Results Of The Meeting Of The Board Of Directors Held On 13Th August, 2018

 This is to inform you that the Board of Directors of the Company, in their meeting held on Monday, 13th August, 2018 (Timings: Meeting commenced at 12.00 Noon and concluded at 1.52 p.m.), have inter-alia considered and approved the Standalone & Consolidated Un-audited Financial Results of the Company for the Quarter ended 30th June, 2018, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015....
13-08-2018
Bigul

Morepen gets twin USFDA approvals

 Morepen Laboratories Ltd has received USFDA (United States Food and Drug Administration) approval for both its bulk drugs manufacturing facilities si
30-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Dear Sir, Please find enclosed Company's press release on 'Twin USFDA approvals for Morepen Labs Bulk Drugs (API) Facilities'. Kindly take it on your record.
30-07-2018
Bigul

Board Meeting Intimation for Intimation Of Rescheduling Of Board Meeting

 MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2018 ,inter alias, to consider and approve This bears reference to the announcement dated July 23, 2018, regarding Board Meeting scheduled on July 31, 2018, to consider and approve the Unaudited Financial Results of the Company for the Quarter ended June 30, 2018. Pursuant to the Regulation 29 and other applicable provisions of...
25-07-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended June 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Thomas P. JoshuaDesignation :- Company Secretary and Compliance Officer
23-07-2018
Bigul

Board Meeting-Closure of Trading Window

 Notice is hereby given, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 31st July, 2018, inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter ended 30th June, 2018....
23-07-2018
Bigul

Notice Of Board Meeting To Be Held On Tuesday, 31St July, 2018

 Notice is hereby given, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 31st July, 2018, inter-alia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Quarter ended 30th June, 2018.
23-07-2018
Bigul

Shareholding for the Period Ended June 30, 2018

 Morepen Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here
21-07-2018
Bigul

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Please find attached transcript of Investor and Analyst Conference Call organised on Friday, 18th May, 2018 at 2.00 p.m. (IST) subsequent to declaration of Audited Financial Results for the quarter and year ended 31st March, 2018. This is for your information and records.
25-06-2018
Bigul

Intimation Under Regulation 33(3)(B)(I) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 33(3)(b)(i) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that in addition to quarterly and year-to-date standalone financial results, Morepen Laboratories Limited will additionally submit quarterly and year-to-date consolidated financial results for the financial year 2018-19.
25-06-2018
Next Page
Close

Let's Open Free Demat Account